Protalix BioTherapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update

CARMIEL, Israel, Oct. 29, 2020 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…


Continue Reading

HEDGE accordingly